USP’s Diane McCarthy on the emerging standards platform and opportunities for stakeholders to help shape standards evolution.
Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
Strategies are reshaping biologics manufacturing by boosting speed, flexibility, and productivity without expanding ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...
This article explores how biobanks, proteomics, and AI are enabling population-scale insights, earlier disease detection, and ...
The United States Patent and Trademark Office has granted the patent titled Endometriosis Biomarkers, providing intellectual ...
It has been confirmed that wasabi (Japanese horseradish) leaves, which have typically been discarded while only the roots are ...
Seer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation ...
Join host Neil Lander as he sits down with Margaret Maziarz, Principal Scientist at Waters Corporation, to discuss the latest tools and strategic approaches to optimizing method development. Margaret ...
Matica Biotechnology, a US subsidiary of Chabiotech, has joined forces with American biotech firm Vaxdom to co-develop an ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...